-
Explore a Clinical Research Study for People with Active Crohn’s Disease
Ozanimod (also known as RPC1063) is an investigational medication being studied for individuals experiencing moderately to severely active Crohn’s disease. Ozanimod is an oral medication, not a biologic, injection or infusion. In this clinical trial, the investigational medication is taken once daily.
-
Explore a Clinical Research Study for People with Active Crohn’s Disease
Ozanimod (also known as RPC1063) is an investigational medication being studied for individuals experiencing moderately to severely active Crohn’s disease. Ozanimod is an oral medication, not a biologic, injection or infusion. In this clinical trial, the investigational medication is taken once daily.
-
Explore a Clinical Research Study for People with Active Crohn’s Disease
Ozanimod (also known as RPC1063) is an investigational medication being studied for individuals experiencing moderately to severely active Crohn’s disease. Ozanimod is an oral medication, not a biologic, injection or infusion. In this clinical trial, the investigational medication is taken once daily.
Now accepting patients with moderately to severely active Crohn’s disease
This website provides information about ozanimod clinical research trials that will test whether the medicine can improve the symptoms of Crohn’s disease.
